Blood Protein May Contribute to Early Development of Atherosclerosis
A study conducted by Dr. Eric Thorin of the Montreal Heart Institute, suggests blood levels of angiopoietin-like protein 2 (angptl2) may represent an...
Webinar: Translating Preclinical Pharmacology in Clinical Activity
Download this webinar to learn how Myriad RBM's products and services were used by VentiRx to compare potency, define PK/PD relationships, identify po...
T-DM1 Most Effective for Aggressive HER2-Positive Breast Cancer
A study presented at this month's American Association for Cancer Research annual meeting by Jose Baselga, M.D., Ph.D., suggests that tumor levels of...
Metabolic Biomarker Associated with Migraine Severity
Migraines, severe headaches that last for greater than four hours, are often characterized by specific symptoms such as nausea, sensitivity to light a...
New Blood-Based Biomarker Assay for the Early Detection of Kidney Cancer
Researchers identified a 3-biomarker immunoassay, measuring NNMT, LCP1, and NM23A, that successfully distinguishes healthy patients from those with re...
Blood-Based Biomarkers Included in Scientific American Timeline of Schizophrenia Research
Less than two hundred years ago schizophrenia emerged from a tangle of mental disorders known simply as madness. Today its diagnosis remains shrouded...
Molecular Sex Differences in Human Serum
A recent article featuring Myriad RBM's services was published in PLoS ONE by a group of researchers investigating the differences in biomarker profil...